Astragalus polysaccharides attenuated inflammation and balanced the gut microflora in mice challenged with Salmonella typhimurium

Int Immunopharmacol. 2019 Sep:74:105681. doi: 10.1016/j.intimp.2019.105681. Epub 2019 Jun 18.

Abstract

Salmonella typhimurium (S. t.) is one of the main pathogens that causes acute gastroenteritis. To evaluate the anti-inflammatory mechanism of Astragalus polysaccharide (APS) in vivo and its influence on the intestinal flora, BALB/c mice were infected with S. t. to establish a model of diarrhea. The disease activity index (DAI) scores showed that APS attenuated S. t.-induced weight loss and diarrhea in mice. APS significantly reduced the index of the liver and spleen as well as the ALT and AST levels in serum (P < 0.05). Hematoxylin and eosin (H&E) results indicated that APS significantly increased jejunum villus height and crypt depth and reduced the infiltration of inflammatory cells (P < 0.05). Additionally, APS increased the tight junction (TJ) proteins expression levels of ZO-1, Occludin and Claudin-1 in the jejunum. The results of 16S rDNA showed that APS significantly increased the number of Lactobacillus and Bifidobacterium spp. to normal levels (compared with the control group). In addition, APS significantly decreased the mRNA expression levels of the proinflammatory cytokines TNF-α, IL-1β, IL-6 and IL-17 in the jejunum (P < 0.01) as well as the proteins expression levels of COX-2 and iNOS (P < 0.05). Western blot confirmed that prefeeding with APS inhibited S. t.-induced expression of TLR4 and MyD88 in the jejunum and further inhibited nuclear factor-κB (NF-κB) activation, including the nuclear translocation of the p65 NF-κB subunit and the phosphorylation and degradation of IκB-α. This was the key to APS inhibition of the production of inflammatory factors and inflammatory mediators in the jejunum.

Keywords: Astragalus polysaccharides; Gut microflora; Intestinal inflammation; Salmonella typhimurium; TLR4/MyD88/NF-κB.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Astragalus Plant / immunology
  • Bifidobacterium / genetics*
  • Cytokines / metabolism
  • Diarrhea / therapy*
  • Disease Models, Animal
  • Gastrointestinal Microbiome / genetics*
  • Humans
  • Inflammation Mediators / metabolism
  • Lactobacillus / genetics*
  • Liver / metabolism*
  • Liver / pathology
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B / metabolism
  • Polysaccharides / therapeutic use*
  • Salmonella Infections / therapy*
  • Salmonella typhimurium / physiology*
  • Signal Transduction
  • Tight Junctions / metabolism*
  • Tight Junctions / pathology

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • Polysaccharides